Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Required for excision 1-B domain containing (REX1BD) is a protein-coding gene in humans, sometimes also known as C19orf60. It encodes an uncharacterized protein with no confirmed molecular function or biological process annotation and does not belong to a well-established protein family such as enzymes, receptors, or ion channels. REX1BD is associated in the literature with certain forms of leprosy, but the nature and significance of this association are not well-defined. There are no experimentally confirmed drugs targeting this protein, and its biological function in health or disease remains unclear. Key points: No confirmed role as a therapeutic target, receptor, enzyme, transporter, or transcription factor. It is notable for its unknown function, with annotations stressing lack of experimental evidence for molecular function or biological process. It is encoded by a single-gene locus on human chromosome 19. There are no known interacting drugs, mechanisms of action, approved biomarkers, or safety concerns due to absence of validated biological activity data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Required for excision 1-B domain containing (REX1BD).